IN-ARMOR

The EU-Horizon funded research concortium – Therepeutic epigenetic enhancement of innate immunity to effectively combat antimicrobial resistance – or IN-ARMOR aims to fight antimicrobial resistance (AMR). AMR and multi-drug resistance have been designated by the World Health Organization as a top 10 health threat of our time.

IN-ARMOR is a granted project by the European Health and Digital Executive Agency (HADEA) under HORIZON-HLTH-2022-DISEASE-06-two-stage call. Its target objective is to introduce a novel class of immune system inducers able to enhance the body’s own innate microbial defense mechanisms to combat AMR and reduce the incidence of the 13 listed most dangerous infections (including 2 of the top 3 priority-1 infections).